Ice Bioscience

Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening

placeBeijing, Beijing, China calendar_todayFounded 2010 groups19 employees language ice-biosci.com

Innovation

53 patent families (25 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies, Physics & computing; filing pace steady. Cited 180 times.

YearFilings
20151
201810
20191
20216
20222
202317
202411
20257
20261

Investor mix

9 investors on record; lead investors include Jifeng Ventures, E-Town International Investment & Development.

Investor typeCountShare
Venture capital444%
Private equity222%
Other / undisclosed333%
Coming soon